Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone

BACKGROUND: To investigate the efficacy and safety of icotinib plus pleurodesis or icotinib alone in epidermal growth factor receptor (EGFR) positive mutant lung cancer patients after malignant pleural effusion (MPE) drainage. METHODS: In this retrospective study from initially reviewed case reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunhua, Fang, Wangsheng, Cheng, Bingye, Chen, Shanshan, Gu, Linping, Zhu, Li, Pan, Yan, Zhou, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330332/
https://www.ncbi.nlm.nih.gov/pubmed/32642157
http://dx.doi.org/10.21037/jtd.2020.03.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330332/
https://www.ncbi.nlm.nih.gov/pubmed/32642157
http://dx.doi.org/10.21037/jtd.2020.03.49

Ejemplares similares